期刊
MOLECULAR & CELLULAR PROTEOMICS
卷 8, 期 5, 页码 883-886出版社
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/mcp.R800015-MCP200
关键词
-
资金
- National Institutes of Health [1U24 CA126476-02]
- NATIONAL CANCER INSTITUTE [U24CA126476] Funding Source: NIH RePORTER
The lack of sensitive, specific, multiplexable assays for most human proteins is the major technical barrier impeding development of candidate biomarkers into clinically useful tests. Recent progress in mass spectrometry-based assays for proteotypic peptides, particularly those with specific affinity peptide enrichment, offers a systematic and economical path to comprehensive quantitative coverage of the human proteome. A complete suite of assays, e. g. two peptides from the protein product of each of the similar to 20,500 human genes (here termed the human Proteome Detection and Quantitation project), would enable rapid and systematic verification of candidate biomarkers and lay a quantitative foundation for subsequent efforts to define the larger universe of splice variants, post-translational modifications, protein-protein interactions, and tissue localization. Molecular & Cellular Proteomics 8: 883-886, 2009.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据